Thanks @garthdaisy.
I think it's important to stress that this product is not a competitor to Admedus but rather a collaborator. The patent you've linked to specifically states that Cardiocel is a suitable material to use in conjunction with this scaffold, implying the recommended use of Cardiocel with the NeoChord product:
"In some embodiments , the region between the valve plane struts, that is in the coaptation zone of the leaflets can include a solid biomaterial positioned therein to increase the surface area for leaflet coaptation , which is particularly useful for patients suffering from functional mitral valve regurgitation . In some such embodiments , the use of web in valve to prevent regurgitation ultimately retrains and reshapes the valve such that the valve leaflets and annulus naturally revert to a more natural configuration to obtain proper coaptation over time . In such embodiments , the biomaterial can be a bioabsorbable material that is absorbed into the body over time . Suitable biomaterials can include , for example , bovine pericardium and CardioCel® ."
- Forums
- ASX - By Stock
- AVR
- Response received from Wayne on LinkedIn
Response received from Wayne on LinkedIn, page-33
-
- There are more pages in this discussion • 108 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$11.90 |
Change
1.050(9.68%) |
Mkt cap ! $251.5M |
Open | High | Low | Value | Volume |
$11.00 | $11.90 | $10.85 | $504.4K | 45.27K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $11.05 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.90 | 99 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 11.050 |
3 | 3407 | 11.000 |
1 | 500 | 10.990 |
1 | 500 | 10.930 |
1 | 915 | 10.900 |
Price($) | Vol. | No. |
---|---|---|
11.900 | 99 | 1 |
11.930 | 80 | 1 |
11.990 | 750 | 1 |
12.000 | 2489 | 1 |
12.050 | 9 | 1 |
Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |